| Description |
Enalapril-[phenyl-d5] maleate is the labelled salt of Enalapril. Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure, diabetic kidney disease, and heart failure. |
| Synonyms |
Enalapril-(phenyl-d5) maleate; (S,S,S)-Enalapril-d5 Maleate; N-[(1S)-1-(Ethoxycarbonyl)-3-(phenyl-d5)propyl]-L-alanyl-L-proline (2Z)-2-Butenedioate; Acapril-d5; Acetensil-d5; Alphrin-d5; Amprace-d5; Enaloc-d5; Enapren-d5; Enapril-d5; Enaprin-d5; Glioten-d5; Hipoartel-d5; Hytrol-d5; Innovace-d5; Innovade-d5; Lapril-d5; Lotrial-d5; MK 421-d5; Reniten-d5; Renivace-d5; Tenace-d5; Unaril-d5; Vasotec-d5; Xanef-d5 |
| IUPAC Name |
(Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-(2,3,4,5,6-pentadeuteriophenyl)butan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
| Related CAS |
76095-16-4 (unlabelled) 75847-73-3 (unlabelled free base)
|
| Canonical SMILES |
CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O |
| InChI |
InChI=1S/C20H28N2O5.C4H4O4/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25;5-3(6)1-2-4(7)8/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25);1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,16-,17-;/m0./s1/i4D,5D,6D,8D,9D; |
| InChI Key |
OYFJQPXVCSSHAI-DQNQMXAMSA-N |
| Melting Point |
34-36 °C |
| Purity |
98% by CP; 98% atom D |
| Solubility |
Soluble in Methanol (Slightly), Water (Slightly) |
| Appearance |
White to Pale Beige Solid |
| Application |
An isotop labelled Enalaprilat. Enalaprilat is the active metabolite of enalapril |
| Shelf Life |
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
| Storage |
Store at -20°C under inert atmosphere |
| Quality Standard |
Enterprise Standard |
![Enalapril-[phenyl-d5] maleate](https://resource.bocsci.com/structure/349554-02-5.gif)
